Isracann Biosciences Stock Price, News & Analysis
Company Description
Isracann Biosciences (OTC Link: ISCNF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $2.0M.
ISCNF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of ISCNF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Isracann Biosciences (ISCNF) stock last traded at $0.0000. At a market capitalization of $2.0M, ISCNF is classified as a micro-cap stock with approximately 175.2M shares outstanding.
Latest News
Isracann Biosciences has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include private placement, management, acquisition. View all ISCNF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ISCNF Company Profile & Sector Positioning
Isracann Biosciences (ISCNF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing ISCNF often look at related companies in the same sector, including Endexx Corp (EDXC), OMID HLDGS INC (OMID), Craftport Cannabis Corp (BHHKF), Radient Tech (RDDTF), and Cannapharmarx (CPMD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ISCNF's relative position within its industry.